Extraction
Conditions
Interventions
This study will be a randomized, controlled, double-blind clinical trial, using the split-mouth model, in which the first surgical intervention (extraction of the lower third molar) will be performed
Sponsors
Livia Bonjardim Lima
Universidade Federal de Uberlândia
Eligibility
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Patients aged between 18 and 30 years. No impairment of general health as per medical history (healthy). Normal physical examination. Patients who agree to participate in the study. Patients with indication for bilateral extraction of mandibular asymptomatic third molars. Third molars in class IIB position, according to the Pell & Gregory classification
Exclusion criteria
Exclusion criteria: History of use of any type of analgesic, anti-inflammatory and antibiotic medication in the 15 days prior to the beginning of the surgical procedure. History of hypersensitivity to drugs, substances or materials used in this experiment. Pregnancy or lactation. Pericoronitis or other local infection within 15 days prior to the surgical procedure. History of systemic disease, such as hypertension, diabetes, or diseases with high oxidative stress, such as favism, severe anemia. Shortest intervention time less than 75% of the time elapsed in the longest intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction in the perception of pain is expected, as assessed by the visual analogue scale, a reduction in edema, as assessed by linear measurements of the face, and a reduction in trismus, measured by the maximum opening of the mouth, based on the verification of the percentage difference between the values ??obtained between the control and test groups | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in quality of life is expected in the postoperative period of third molar extraction, measured using a questionnaire on the impact of oral health on quality of life. A decrease in the postoperative consumption of analgesic medication is expected in the test group | — |
Countries
Brazil
Contacts
Public ContactLivia Lima
Universidade Federal de Uberlândia
Outcome results
None listed